Changes in Companion Diagnostic Labelling: Implementation of FDA's April 2020 Guidance for Industry for In Vitro CDx Labeling for Specific Oncology Therapeutic Groups.
In: Therapeutic Innovation & Regulatory Science, Jg. 56 (2022-09-01), Heft 5, S. 689-697
Online
academicJournal
Zugriff:
Titel: |
Changes in Companion Diagnostic Labelling: Implementation of FDA's April 2020 Guidance for Industry for In Vitro CDx Labeling for Specific Oncology Therapeutic Groups.
|
---|---|
Autor/in / Beteiligte Person: | Cooper, Lisa ; Chen, Joyce |
Link: | |
Zeitschrift: | Therapeutic Innovation & Regulatory Science, Jg. 56 (2022-09-01), Heft 5, S. 689-697 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 2168-4790 (print) |
DOI: | 10.1007/s43441-022-00422-z |
Sonstiges: |
|